Skip to content

Intrathecal contrast-enhanced MRI for investigation of cerebrospinal fluid transportation

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520146-33-00
Enrollment
60
Registered
2025-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrospinal fluid circulation disorder seen in clinically suspected idiopathic normal pressure hydrocephalus

Brief summary

Time-dependent change in signal intensity on brain MRI after intrathecal contrast administration will be analyzed with indicator dilution algorthim that will be optimized using computational fluid dynamic simulations., Registration of possible adverse events related to the intrathecal injection of Gadovist

Detailed description

Comparision between the distribution of the contrast and other MRI-sequences and cerebrospinal fluid dynamic parameters which provides us with information regarding possible driving mechanisms for the distribution., Quantified pre-operative glymphatic function will be correlated to clinical improvment after CSF shunting of INPH patients

Interventions

Sponsors

Region Vaesterbotten
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Time-dependent change in signal intensity on brain MRI after intrathecal contrast administration will be analyzed with indicator dilution algorthim that will be optimized using computational fluid dynamic simulations., Registration of possible adverse events related to the intrathecal injection of Gadovist

Secondary

MeasureTime frame
Comparision between the distribution of the contrast and other MRI-sequences and cerebrospinal fluid dynamic parameters which provides us with information regarding possible driving mechanisms for the distribution., Quantified pre-operative glymphatic function will be correlated to clinical improvment after CSF shunting of INPH patients

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026